← FDA DRUG APPROVALS

FDA ANDA · ANDA076032

METHYLPHENIDATE HYDROCHLORIDE

Sponsor: ABLE

APPLICATION
ANDA076032
TYPE
ANDA
ORIGINAL APPROVAL
2001-05-09
LATEST ACTION
2003-11-18
ROUTE
ORAL
DOSAGE FORM
TABLET, EXTENDED RELEASE
MARKETING STATUS
Discontinued

Products

METHYLPHENIDATE HYDROCHLORIDEDiscontinued
METHYLPHENIDATE HYDROCHLORIDE 20MG · TABLET, EXTENDED RELEASE · ORAL

Approval history

2003-11-18Labeling · Supplement 3AP
2003-03-05Labeling · Supplement 2AP
2001-10-16Manufacturing (CMC) · Supplement 1AP
2001-05-09OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →